Presentation TCT 2024

TCT 696: Survival Benefit of Optimal Glycemic Control in Diabetic Patients Undergoing Endovascular Therapy for Femoropopliteal Disease

Presenter: Jae Young Jeung

October 28, 2024

REGISTER for free or LOG IN to view this content

TCT 696: Survival Benefit of Optimal Glycemic Control in Diabetic Patients Undergoing Endovascular Therapy for Femoropopliteal Disease

Endovascular

TCT 2024

Venous

Up Next

Presentation TCT 2024

TCT 515: Myocardial Blood Flow Distribution Derived From CCTA, Myocardium at Risk, and Revascularization Completeness in FASTTRACK CABG

Presenter: Patrick W. Serruys

October 28, 2024

More slides +

Presentation TCT 2024

TCT 933: Win Ratio Analysis of LANDMARK Trial: Myval Transcatheter Heart Valve vs Contemporary Standard Valves (Sapien and Evolut) in Patients With Severe Aortic Stenosis

Presenter: Patrick W. Serruys

October 28, 2024

Presentation TCT 2024

TCT 895: Ultra-Low Volume Contrast Aortogram With Rapid Pacing for Co-Planar Annular Opacification Before Transcatheter Aortic Valve Deployment

Presenter: Tanya Sharma

October 28, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.